Angiotensin AT1 and AT2 receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation

Circulation Research

Volumn 88, Issue 1, 2001, Pages 22-29

  Fujiyama, Soichiro ^a   Matsubara, Hiroaki ^a   Nozawa, Yoshihisa ^b   Maruyama, Katsuya ^a   Mori, Yasukiyo ^a   Tsutsumi, Yoshiaki ^a   Masaki, Hiroya ^a   Uchiyama, Yoko ^a   Koyama, Yoko ^a   Nose, Atsuko ^a   Iba, Osamu ^a   Tateishi, Eriko ^a   Ogata, Nahoko ^a   Jyo, Nobuo ^a   Higashiyama, Shigeki ^c   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Angiopoietin; Angiotensin II; Endothelial cell; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 2; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; COLLATERAL CIRCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0035910614     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.88.1.22     Document Type: Article

References (47)

1. Mechanisms of angiogenesis
2. Failure of blood-island formation and vasculogenesis in FLK-1 deficient mice
3. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
4. Clinical applications of angiogenic growth factors and their inhibitors
5. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
6. Angiogenesis in ischemic heart disease
7. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
8. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
9. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells
10. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
11. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
12. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2
13. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
14. Isolation of angiopoietin-1, a ligand for the TIE receptor, by secretion-trap expression cloning
15. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
16. Tie2 receptor ligands, angiopoietin-2, modulate VEGF-induced postnatal neovascularization
17. Direct intramuscular injection of plasmid DNA angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb
18. Vascular endothelial growth factor and the angiopoietins: Working together to built a better blood vessel
19. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia
20. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells
21. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
22. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system
23. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: Up-regulation of essential transcription factor for angiogenesis, ets
24. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells
25. Interleukin-1β upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases
26. Neovascularization produced by angiotensin II
27. Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane
28. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure
29. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells
30. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells
31. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
32. Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor
33. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor
34. Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-β synthesis via transcriptional and post-transcriptional mechanisms
35. Role of calcium-sensitive tyrosine kinase PYK2/CAKβ/RAFTK in angiotensin II-induced Ras/ERK signaling
36. Mechanical stretch induces enhanced expression of angiotensin II receptors in neonatal rat cardiac myocytes
37. Growth/differentiation factor-5 induces angiogenesis in vivo
38. Effects of angiotensin-converting enzyme inhibitor, cilazapril, on congestive heart failure in cardiomyopathic hamsters
39. Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure
40. Angiotensin II signal transduction in vascular smooth muscle: Role of tyrosine kinases
41. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
42. Pathophysiological roles of angiotensin II type 2 receptor in cardiovascular and renal diseases
43. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system
44. Induction of heparin-binding epidermal growth-factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells
45. Heparin-binding EGF-like growth factor
46. 1 receptor and PKC activation
47. Vascular endothelial growth factor induces expression of the antiapoptotic proteins bcl2 and A1 in vascular endothelial cells